TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma. Lazarian G, Chemali L, Bensalah M, Zindel C, et al. Am J Hematol 2025 Mar 6. doi: 10.1002/ajh.27650.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lazarian G, Chemali L, Bensalah M, Zindel C, et al. TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma. Am J Hematol 2025 Mar 6. doi: 10.1002/ajh.27650.
PMID: 40047370